Anixa Biosciences(ANIX) - 2020 Q3 - Quarterly Report
Anixa Biosciences(ANIX)2020-09-08 20:30UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2020 Commission file number 001-37492 ANIXA BIOSCIENCES, INC. | --- | --- | |----------------------------------------------------------------------------|----------------------------------------------| | (Exact name of registrant as \nDelaware | specified in its charter) \n11-2622630 | | (State or oth ...